News Releases News Releases Year None202220212020201920182016 Aug, 4 2022 TransMedics Announces Upsize and Pricing of Public Offering of Common Stock Aug, 3 2022 TransMedics Announces Proposed Public Offering of Common Stock Aug, 1 2022 TransMedics Reports Second Quarter 2022 Financial Results Jul, 26 2022 TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference Jul, 18 2022 TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022 Jun, 3 2022 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May, 3 2022 TransMedics Reports First Quarter 2022 Financial Results Apr, 28 2022 TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication Apr, 21 2022 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Apr, 19 2022 TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022 Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
News Releases Year None202220212020201920182016 Aug, 4 2022 TransMedics Announces Upsize and Pricing of Public Offering of Common Stock Aug, 3 2022 TransMedics Announces Proposed Public Offering of Common Stock Aug, 1 2022 TransMedics Reports Second Quarter 2022 Financial Results Jul, 26 2022 TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference Jul, 18 2022 TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022 Jun, 3 2022 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May, 3 2022 TransMedics Reports First Quarter 2022 Financial Results Apr, 28 2022 TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication Apr, 21 2022 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Apr, 19 2022 TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022 Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
